VC firms
Swelife - The Swedish national strategic innovation programme for life science. Financed by Vinnova and the projects' partners.
Overview
Location
Sweden, Lund
Phone
+46 72 554 16 34
Investment Type
Accelerator
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 31, 2023 | Funding received from Swelife for the development of a new treatment for COPD and severe asthma | Funding received from Swelife for the development of a new treatment for COPD and severe asthma Fri, Mar 31, 2023 09:19 CET Report this content Arcede Pharma AB announces that a consortium consisting of Arcede Pharma, Iconovo and Lund Unive... |
| Apr 4, 2022 | Biomedical Bonding secures 3 MSEK in funding for its Bonevolent™ implants for treatment of fractures | Biomedical Bonding secures 3 MSEK in funding for its Bonevolent™ implants for treatment of fractures Mon, Apr 04, 2022 10:00 CET Report this content Press release: Biomedical Bonding AB has, together with consortium partners KTH Royal Insti... |
Reviews 0
FAQ about SWElife
What has the press written about SWElife?
Parsers VC has collected 3 articles mentioning SWElife, among them “Funding received from Swelife for the development of a new treatment for COPD and severe asthma” (Mar 31, 2023) and “Biomedical Bonding secures 3 MSEK in funding for its Bonevolent™ implants for treatment of fractures” (Apr 4, 2022).
Is SWElife still active?
Yes, SWElife is active.